Reliability of Ventricular Remodeling as a Surrogate for Use in Conjunction With Clinical Outcomes in Heart Failure-Reference-Cited by-同舟云学术

Reliability of Ventricular Remodeling as a Surrogate for Use in Conjunction With Clinical Outcomes in Heart Failure

Published:2005-09 Issue:6 Volume:96 Page:867-871
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Konstam Marvin A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference46 articles.

1. Heart Disease and Stroke Statistics—2004 Update,2003

2. Ventricular remodeling in heart failure;Konstam;J Card Failure,2003

3. Remodeling as an end-point in heart failure therapy;Cohn;Cardiovasc Drugs Ther,2004

4. Surrogate endpoints in heart failure;Anand;J Am Coll Cardiol,2002

5. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure;Cohn;Circulation,1993

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LVAD therapy as a catalyst to heart failure remission and myocardial recovery;Clinical Cardiology;2023-08

2. Transcatheter Left Ventricular Restoration in Patients With Heart Failure;Journal of Cardiac Failure;2023-07

3. Heart failure with recovered ejection fraction: Current understanding and future prospects;The American Journal of the Medical Sciences;2023-01

4. Uric Acid Predicts Recovery of Left Ventricular Function and Adverse Events in Heart Failure With Reduced Ejection Fraction: Potential Mechanistic Insight From Network Analyses;Frontiers in Cardiovascular Medicine;2022-07-15

5. The use of angiotensin II receptor blocker is associated with greater recovery of cardiac function than angiotensin‐converting enzyme inhibitor in dilated cardiomyopathy;ESC Heart Failure;2022-02-08